TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,342
|
11,808
|
6,045 |
Financial expenses |
0
|
1
|
0 |
Earnings before taxes |
2,339
|
2,342
|
-110 |
EBITDA |
2,709
|
2,614
|
71 |
Total assets |
9,815
|
7,489
|
4,015 |
Current assets |
7,147
|
4,481
|
2,618 |
Current liabilities |
3,520
|
3,176
|
1,532 |
Equity capital |
6,166
|
4,313
|
2,483 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
4
|
3
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.8%
|
57.6%
|
61.8% |
Turnover per employee |
3,336
|
3,936 | |
Profit as a percentage of turnover |
17.5%
|
19.8%
|
-1.8% |
Return on assets (ROA) |
23.8%
|
31.3%
|
-2.7% |
Current ratio |
203.0%
|
141.1%
|
170.9% |
Return on equity (ROE) |
37.9%
|
54.3%
|
-4.4% |
Change turnover |
1,499
|
6,253
|
874 |
Change turnover % |
13%
|
113%
|
17% |
Chg. No. of employees |
1
|
3
|
0 |
Chg. No. of employees % | 33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.